BRIMONIDINE TARTRATE AND TIMOLOL MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Brimonidine Tartrate And Timolol Maleate, and what generic alternatives are available?
Brimonidine Tartrate And Timolol Maleate is a drug marketed by Alembic, Apotex, Florida, Glenmark Pharms Ltd, Sandoz, Sentiss, Somerset, and Upsher Smith Labs. and is included in eight NDAs.
The generic ingredient in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brimonidine Tartrate And Timolol Maleate
A generic version of BRIMONIDINE TARTRATE AND TIMOLOL MALEATE was approved as brimonidine tartrate; timolol maleate by SANDOZ on April 4th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
- What are the global sales for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
- What is Average Wholesale Price for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE?
Summary for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 6 |
| Patent Applications: | 42 |
| What excipients (inactive ingredients) are in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE? | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE excipients list |
| DailyMed Link: | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE at DailyMed |
Recent Clinical Trials for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Allergan | Phase 3 |
| Allergan | |
| Allergan | Phase 4 |
See all BRIMONIDINE TARTRATE AND TIMOLOL MALEATE clinical trials
Pharmacology for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
| Drug Class | alpha-Adrenergic Agonist beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Antagonists |
US Patents and Regulatory Information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 215230-001 | Aug 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Somerset | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 216114-001 | Sep 10, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glenmark Pharms Ltd | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 214987-001 | May 16, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 215598-001 | Dec 12, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
